| Identification | Back Directory | [Name]
CARCINOEMBRYONIC ANTIGEN (CEA) | [CAS]
168635-85-6 | [Synonyms]
CARCINOEMBRYONIC ANTIGEN (CEA)
L-Leucine, L-tyrosyl-L-leucyl-L-serylglycyl-L-alanyl-L-asparaginyl-L-leucyl-L-asparaginyl- | [Molecular Formula]
C43H69N11O14 | [MOL File]
168635-85-6.mol | [Molecular Weight]
964.07 |
| Chemical Properties | Back Directory | [Boiling point ]
1471.7±65.0 °C(Predicted) | [density ]
1.289±0.06 g/cm3(Predicted) | [storage temp. ]
-20°C, protect from light | [form ]
Solid | [pka]
3.35±0.10(Predicted) | [color ]
White to off-white | [Water Solubility ]
Soluble in Water | [Sequence]
H-Tyr-Leu-Ser-Gly-Ala-Asn-Leu-Asn-Leu-OH |
| Hazard Information | Back Directory | [Uses]
Carcinoembryonic antigen peptide 1 (CEA peptide) is a carcinoembryonic antigen (CEA)-derived peptide. Carcinoembryonic antigen peptide 1 is a potential HLA-A*0201-restricted CTL epitope that can be used for the study of CTL-mediated epithelial-derived cancers[1]. | [storage]
-20°C, protect from light | [References]
[1] Ras E, et al. Identification of potential HLA-A* 0201 restricted CTL epitopes derived from the epithelial cell adhesion molecule (Ep-CAM) and the carcinoembryonic antigen (CEA)[J]. Human immunology, 1997, 53(1): 81-89. DOI:10.1016/S0198-8859(97)00032-3 |
|
|